BG
ESPR

BlackRock Group’s Esperion Therapeutics ESPR Stock Holding History

BlackRock Group’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$72K Buy
5,811
+504
+9% +$6K ﹤0.01% 2878
2016
Q3 		$74K Sell
5,307
-88
-2% -$997 ﹤0.01% 2863
2016
Q2 		$52K Sell
5,395
-72
-1% -$1.19K ﹤0.01% 2907
2016
Q1 		$93K Buy
5,467
+1,617
+42% +$26K ﹤0.01% 2785
2015
Q4 		$86K Sell
3,850
-96
-2% -$2.42K ﹤0.01% 2728
2015
Q3 		$93K Buy
3,946
+802
+26% +$50.3K ﹤0.01% 2723
2015
Q2 		$257K Buy
3,144
+1,535
+95% +$150K ﹤0.01% 2512
2015
Q1 		$149K Buy
+1,609
New +$104K ﹤0.01% 2569
2013
Q4 		– Sell
-32,044
Closed -$604K – 2702
2013
Q3 		$604K Buy
+32,044
New +$538K ﹤0.01% 2150

Other funds holding ESPR

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return